Cytrx reported 38.78K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Bioline Rx BLRX:US $ 20.87M 0.38M
Brainstorm Cell Therapeutics BCLI:US $ 0.01M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0.01M
Curis CRIS:US $ 0.92M 0M
Cytrx CYTR:US 38.78K 2K
Glaxosmithkline GSK:US $ 1347M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Northwest Biotherapeutics NWBO:US 892K 35K
Novartis NVS:US $ 901M 12M
Seattle Genetics SGEN:US $ 0.18M 0M
Takeda 4502:JP Y 1676263M 7138M